Perfusion Assessment in Laparoscopic Left Anterior Resection (PILLAR II)

This study is currently recruiting participants.
Verified September 2012 by Novadaq Technologies Inc.
Sponsor:
Information provided by (Responsible Party):
Novadaq Technologies Inc.
ClinicalTrials.gov Identifier:
NCT01560377
First received: March 19, 2012
Last updated: January 7, 2013
Last verified: September 2012
  Purpose

The purpose of this study is to demonstrate that NIR fluorescence angiography using the PINPOINT Endoscopic Fluorescence Imaging System ("PINPOINT System" or "PINPOINT") can assess viability of colon tissue during laparoscopic left colectomy. This information will provide the surgeon with clinically relevant information in assessing whether or not the tissue has adequate blood supply in the lower section of the colon prior to a colectomy.


Condition Intervention Phase
Laparoscopic Left Colectomy
Device: The PINPOINT Endoscopic Fluorescence Imaging System
Phase 1

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Open Label Clinical Study to Demonstrate the Utility of Intra-operative Perfusion Assessment Using NIR Fluorescence Angiography With the PINPOINT® Endoscopic Fluorescence Imaging System and to Assess the Impact of PINPOINT on the Surgical Decision Making Process and on Surgical Outcomes in Laparoscopic Left Anterior Resection Procedures

Resource links provided by NLM:


Further study details as provided by Novadaq Technologies Inc.:

Primary Outcome Measures:
  • Incidence of use of PINPOINT System to aid in surgical colectomies decision making. [ Time Frame: Day of procedure - Day 1 ] [ Designated as safety issue: No ]
    To demonstrate the utility of intra-operative assessment of colon perfusion, using the PINPOINT System to optimize the location at which to transect the colon in laparoscopic left colectomies and to assess mucosal perfusion of the completed anastomosis following proximal anastomosis in laparoscopic left colectomy.


Secondary Outcome Measures:
  • Incidence of all other operative complications [ Time Frame: through hospital discharge or at 30 days post procedure, whichever is later ] [ Designated as safety issue: Yes ]
    To assess safety related outcomes of the laparoscopic left colectomies with intra-operative assessment of perfusion using the PINPOINT Endoscopic Fluorescence Imaging System for guidance.


Estimated Enrollment: 150
Study Start Date: May 2012
Estimated Study Completion Date: June 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Imaged subjects
Subjects imaged for laparoscopic left colectomy in the lower tract.
Device: The PINPOINT Endoscopic Fluorescence Imaging System
The PINPOINT system will be used to provide real-time endoscopic visible and endoscopic NIR fluorescence imaging. PINPOINT enables surgeons to perform routine visible light endoscopic procedures as well as further visually assess vessels, blood flow and related tissue perfusion with near infra-red imaging during minimally invasive surgery

Detailed Description:

Colectomy is a surgical procedure in which a part or all of the colon is removed. It is used to treat a variety of diseases including colon cancer, diverticulitis, inflammatory bowel disease (including ulcerative colitis or Crohn's disease) and infarcted bowel.

This study is the second phase of a three phase process to demonstrate the clinical utility of perfusion assessment by NIR fluorescence angiography in colectomy. The initial phase (Phase I) consisted of a number of small investigative studies that have now been completed. Upon successful completion of this study, it is anticipated that a prospective, multi center, randomized trial will be conducted (Phase III). Information learned from this present study will help guide the design of the randomized trial e.g. specific patient populations that may best benefit from this imaging modality and how randomization should be conducted (e.g. imaged cohort vs. non imaged, or all subjects imaged but then randomized to no image assessment in one arm of the study).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subject is scheduled for laparoscopic left colectomy in the lower region (planned anastomosis located 5 - 15 cm from anal verge)
  • A negative pregnancy test for women of childbearing potential prior to surgery

Exclusion Criteria:

  • Subject has a previous history of adverse reaction or known allergy to ICG, iodine or iodine dyes
  • Subject has any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure
  • Subject is a pregnant or lactating female
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01560377

Locations
United States, California
University of California, Irvine Recruiting
Orange, California, United States, 92868
Contact: Carlos Chavez, MD     714-456-6262     ChavezC@uci.edu    
Principal Investigator: Michael Stamos, MD            
University of California San Diego Recruiting
San Diego, California, United States, 92093
Contact: Allan Mark Asuncion     858-349-6900     aasuncion@ucsd.edu    
Principal Investigator: Elisabeth McLemore, MD            
United States, Florida
Cleveland Clinic Florida Recruiting
Weston, Florida, United States, 33331
Contact: Jorge Canedo         canedoj@ccf.org    
Principal Investigator: Steve Wexner, MD            
United States, New York
Beth Israel Medical Center Recruiting
New York, New York, United States, 10003
Contact: Vicki L Brooks     504-842-5495     vbrooks@chpnet.org    
Principal Investigator: Joseph Martz, MD            
United States, Ohio
University Hospital Case Medical Center Recruiting
Cleveland, Ohio, United States, 44106
Contact: Christina Seafler, RN     216-844-4706     christina.seafler@uhhospitals.org    
Principal Investigator: Conor Delaney, MD            
Sponsors and Collaborators
Novadaq Technologies Inc.
  More Information

No publications provided

Responsible Party: Novadaq Technologies Inc.
ClinicalTrials.gov Identifier: NCT01560377     History of Changes
Other Study ID Numbers: Version 1
Study First Received: March 19, 2012
Last Updated: January 7, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Novadaq Technologies Inc.:
laparoscopic left colectomy,colectomy,

ClinicalTrials.gov processed this record on June 18, 2013